Successful eltrombopag treatment of severe refractory thrombocytopenia in chronic myelomonocytic leukemia: Two cases reports: A CARE-compliant article

RATIONALE: Thrombocytopenia in chronic myelomonocytic leukemia (CMML) is usually attributed to impaired marrow production resulting from cytotoxic drug use or CMML itself (“CMML-induced thrombocytopenia”). In very rare cases, immune thrombocytopenia (ITP) can be a complication of CMML (“CMML-associa...

Descripción completa

Detalles Bibliográficos
Autores principales: Gao, Yayue, Gong, Ming, Zhang, Chunxia, Kong, Xudong, Ma, Yigai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2017
Materias:
4800
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5671840/
https://www.ncbi.nlm.nih.gov/pubmed/29069007
http://dx.doi.org/10.1097/MD.0000000000008337

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5671840/
https://www.ncbi.nlm.nih.gov/pubmed/29069007
http://dx.doi.org/10.1097/MD.0000000000008337

Ejemplares similares